Physician profile
Marc A Mitchell
NPI 1265620363
$5,425.74
in general payments reported to CMS, 2019-2025
17 companies · $25.61 in 2025
The $25.61 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,648 · 2020: $68.72 · 2021: $183 · 2022: $178 · 2023: $157 · 2024: $165 · 2025: $25.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Srs Medical Systems, INC. | $3,500.00 | 2019 | |
| Neotract INC. | $1,062.35 | 2019-2020 | |
| Procept Biorobotics Corporation | $168.64 | 2021 | |
| Boston Scientific Corporation | $100.25 | 2020-2024 | Moses 550 Dfl |
| Laborie Medical Technologies Corp. | $94.13 | 2023-2024 | Endosheath Technology |
| Teleflex LLC | $90.18 | 2022-2025 | Urolift |
| Axonics, INC. | $75.14 | 2022-2023 | Axonics |
| Progenics Pharmaceuticals, INC. | $57.14 | 2023-2024 | Pylarify |
| Myriad Genetic Laboratories, INC. | $55.32 | 2022 | |
| Astellas Pharma US INC | $46.86 | 2019 | |
| Medtronic USA, INC. | $35.62 | 2019 | |
| Urovant Sciences INC | $29.85 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $25.58 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $24.93 | 2022 | |
| Calyxo, INC. | $23.97 | 2024 | Cvac Aspiration System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $21.51 | 2019 | |
| Abbvie INC. | $14.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.